Show
Sort by
-
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction : the LIFE‐HF model
-
Fibroblast growth factor 23 and the quest for the Holy Grail in heart failure : will the Crusaders be forced to surrender?
-
Effects of organic and inorganic nitrate on aortic and carotid haemodynamics in heart failure with preserved ejection fraction
-
Prevalence of potential cardiac resynchronization therapy candidates and actual use of cardiac resynchronization therapy in patients hospitalized for heart failure
-
Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients
-
Response of the oxygen uptake efficiency slope to exercise training in patients with chronic heart failure
-
The effects of an aging vascular model on healthy and diseased hearts
-
Relationship between QRS duration, left ventricular volumes and prevalence of nonviability in patients with coronary artery disease and severe left ventricular dysfunction
-
Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: differences between primary and secondary prophylaxis
-
Colour M-mode velocity propagation: a glance at intra-ventricular pressure gradients and early diastolic ventricular performance
-
Guiding and optimization of resynchronization therapy with dynamic three-dimensional echocardiography and segmental volume-time curves: a feasibility study
-
In vitro study of FFR, QCA and IVUS for the assessment of optimal stent deployment